News | News By Subject | News by Disease News By Date | Search News

Asthma News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Breath Therapeutics Holding BV Spins Out of PARI Pharma With $46 Million and a Ready-to-Go Phase III Drug/Device Combo     3/9/2017
Synairgen (SNG.L) Stock Tanks After Partner AstraZeneca PLC (AZN) Halts Asthma Drug Trial     10/12/2016
AstraZeneca PLC (AZN)'s Asthma Candidate Does Well in Final Late-Stage Test     9/6/2016
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials     9/1/2016
Vectura (VEC.L)'s Asthma Med Flutiform Flunks Final Late-Stage Study     8/30/2016
AstraZeneca PLC (AZN) Announces Positive Top-Line Data From Two Phase III SYMBICORT Studies     8/10/2016
Novartis AG (NVS)'s New Asthma Drug Hailed a Game-Changer After Success in Small Trial     8/9/2016
GlaxoSmithKline (GSK) Bets $230 Million on Johnson & Johnson (JNJ)'s Asthma Drug     7/27/2016
FDA Green Lights Genentech (RHHBY)'s Xolair for Allergic Asthma in Kids     7/11/2016
AstraZeneca PLC (AZN)'s Asthma Drug Hits Phase III Goal, Predicted to Reach Market in 2017     5/18/2016
Sorrento (SRNE) Reports Positive Data from Combined Phase II & III Clinical Study Of STI-004     5/16/2016
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project     3/17/2016
AbbVie (ABBV) Coughs Up $595 Million+ for Boehringer Ingelheim's Psoriasis and Crohn’s Drugs     3/8/2016
Amid Fierce Competition from GlaxoSmithKline (GSK), AstraZeneca PLC (AZN) and Teva (TEVA), Two of Genentech (RHHBY)'s Asthma Drug Trials Disappoint     3/1/2016
FDA Green Lights GlaxoSmithKline (GSK)'s Nucala for Severe Asthma     11/5/2015

News from Around the Web
GlaxoSmithKline (GSK) Is Voluntarily Recalling 593,000 Ventolin Asthma Inhalers     4/5/2017
How Researchers Used A Smartphone To Study Asthma, Nature Biotechnology Reveals     3/15/2017
Danish Study Links Fish Oil During Pregnancy With Lower Asthma Risk In Kids, University of Copenhagen Reveals     12/29/2016
Wireless Connected Metered Dose Inhaler Tracks Medication Compliance, H&T Presspart Reveals     12/15/2016
How To Turn A Smartphone Into An Asthma Device     12/7/2016
Australian Asthma Storm Claims Sixth Victim     11/28/2016
Fighting For The Next Asthma Blockbuster: Italy Gets In The Way Of Novartis AG (NVS)     11/22/2016
Wearable Device Could Help Prevent Asthma Attacks, Quvium Reveals     9/28/2016
New Drug Shows Capability To Help People With Severe Asthma, Wake Forest University Baptist Medical Center Study     9/13/2016
Vitamin D May Help Reduce Asthma Attacks, Cochrane Review Finds     9/6/2016
NC State Research Center Develops Asthma Detection Technology     7/21/2016
New Devices, Wearable System Aim To Predict, Prevent Asthma Attacks, North Carolina State University Study     6/2/2016
3M Drug Delivery Systems Designs An "Intelligent Inhaler" System For COPD, Asthma And Other Respiratory Ills     4/26/2016
Women Smokers And Drinkers With Unhealthy BMIs At Two-Fold Higher Risk Of Asthma, St. Michael's Hospital Study Reveals     4/7/2016
Moms Who Eat Oily Fish During Pregnancy May Reduce Asthma Risk In Kids, University of Southampton Study     4/7/2016

Press Releases
Cincinnati Children's Hospital Medical Center Release: Experimental Drug Targets Nucleus Of Allergen-Sensitized Cells     4/19/2017
How Researchers Used A Smartphone To Study Asthma, Nature Biotechnology Reveals     3/15/2017
Rho Supports Manuscript Establishing Key Metrics For The Composite Asthma Severity Index     3/7/2017
GlaxoSmithKline (GSK)'s MUSCA Study Shows Nucala (Mepolizumab) Significantly Improves Quality Of Life And Lung Function In Severe Asthma Patients With An Eosinophilic Phenotype     3/6/2017
Cynata Advances Development Of Cymerus MSCs For The Treatment Of Asthma     3/2/2017
ALK-Abello A/S's ACARIZAX Data Results In Significant Change To The GINA Asthma Management Strategy: Sublingual Allergy Immunotherapy (SLIT) Recommended As A Treatment Option In Patients With House Dust Mite Allergic Asthma     2/27/2017
GlaxoSmithKline (GSK) Release: Positive Results For Relvar Ellipta Lung Function Study In Patients With Well-Controlled Asthma     2/23/2017
Boehringer Ingelheim Release: FDA Expands Approval Of SPIRIVA RESPIMAT (Tiotropium Bromide) Inhalation Spray For Maintenance Treatment Of Asthma In Children     2/16/2017
Boehringer Ingelheim Release: FDA Expands Approval Of Tiotropium Respimat For Maintenance Treatment Of Asthma In Children     2/16/2017
Aviragen (AVIR) Tanks Some More After Reporting a Second Trial Failure This Month     2/14/2017
Teva (TEVA) Announces FDA Approval Of Two New RespiClick Maintenance Inhalers For The Treatment Of Asthma     1/30/2017
Vectura (VEC.L) Release: FDA Approves IND To Support Company’s Wholly-Owned Programme VR647 In Paediatric Asthma     1/24/2017
Knopp Biosciences Receives Key Patent Directed To Treatment For Hypereosinophilic Syndromes, Asthma, And Other Eosinophilic Diseases     1/4/2017
Mundipharma AG Signs New Deal With Vectura Limited For Global Development And Commercialization Of Inhaled Triple Therapy VR2076 For The Treatment Of Asthma And COPD     12/27/2016
Theravance Biopharma (TBPH) Highlights Initiation Of Phase 3 Study Of The Closed Triple In Patients With Asthma By GlaxoSmithKline (GSK) And Innoviva     12/20/2016